Isoalantolactone protects against Staphylococcus aureus pneumonia

FEMS Microbiology Letters

Volumn 324, Issue 2, 2011, Pages 147-155

  Qiu, Jiazhang ^a   Luo, Mingjing ^a   Wang, Jianfeng ^a   Dong, Jing ^a   Li, Hongen ^a   Leng, Bingfeng ^a   Zhang, Qian ^a   Dai, Xiaohan ^a   Zhang, Yu ^a   Niu, Xiaodi ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

toxin; Antivirulence; Isoalantolactone; Pneumonia; Staphylococcus aureus

Indexed keywords

ALPHA TOXIN; ANTIINFECTIVE AGENT; ISOALANTOLACTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL TOXINS; CELL LINE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INULA; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PNEUMONIA, STAPHYLOCOCCAL; SESQUITERPENES; STAPHYLOCOCCUS AUREUS;

ASTERACEAE; BACTERIA (MICROORGANISMS); INULA HELENIUM; MUS; STAPHYLOCOCCUS AUREUS;

EID: 80054097504     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02397.x     Document Type: Article

References (38)

1. Bartlett AH, Foster TJ, Hayashida A & Park PW (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 198: 1529-1535.
2. Bernardo K, Pakulat N, Fleer S, Schnaith A, Utermöhlen O, Krut O, Müller S & Krönke M (2004) Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48: 546-555.
3. Bubeck Wardenburg J & Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205: 287-294.
4. Bubeck Wardenburg J, Patel RJ & Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75: 1040-1044.
5. Cegelski L, Marshall GR, Eldridge GR & Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev Microbiol 6: 17-27.
6. Chan PF & Foster SJ (1998) Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 180: 6232-6241.
7. Cheung AL & Zhang G (2002) Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front Biosci 7: d1825-d1842.
8. Clinical and Laboratory Standards Institute (2005) Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI/NCCLS document M100-S15. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA.
9. Gouaux E (1998) alpha-Hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. J Struct Biol 121: 110-122.
10. Hirst RA, Yesilkaya H, Clitheroe E, Rutman A, Dufty N & Mitchell TJ (2002) Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infect Immun 70: 1017-1022.
11. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC et al. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. P Natl Acad Sci USA 101: 9786-9791.
12. Hung DT, Shakhnovich EA, Pierson E & Mekalanos JJ (2005) Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310: 670-674.
13. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298: 1763-1771.
14. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL & Jernigan DB (2005) Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 11: 868-872.
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
16. Levy SB, FitzGerald GB & Macone AB (1976) Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature 260: 40-42.
17. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y & Otto M (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. P Natl Acad Sci USA 106: 5883-5888.
18. Liang X, Yan M & Ji Y (2009) The H35A mutated alpha-toxin interferes with cytotoxicity of staphylococcal alpha-toxin. Infect Immun 77: 977-983.
19. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH & Oldfield E (2008) A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319: 1391-1394.
20. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
21. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(suppl 2): S27-S72.
22. McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF & Foster TJ (1999) Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 67: 5541-5544.
23. Nguyen HM & Graber CJ (2010) Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother 65: 24-36.
24. Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M & Rubens CE (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64: 3818-3826.
25. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B & Moghazeh S (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12: 3967-3975.
26. Ohlsen K, Ziebuhr W, Koller KP, Hell W, Wichelhaus TA & Hacker J (1998) Effects of subinhibitory concentrations of antibiotics on alpha toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 42: 2817-2823.
27. O'Reilly M, de Azavedo JC, Kennedy S & Foster TJ (1986) Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog 1: 125-138.
28. Patel AH, Nowlan P, Weavers ED & Foster T (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 55: 3103-3110.
29. Paul M & Leibovici L (2009) Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses. Infect Dis Clin North Am 23: 277-293.
30. Qiu J, Wang D, Xiang H, Feng H, Jiang Y et al. (2010) Subinhibitory concentrations of thymol reduce enterotoxins A and B and α-hemolysin production in Staphylococcus aureus isolates. PLoS ONE 5: e9736.
31. Ragle BE & Bubeck Wardenburg J (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 77: 2712-2718.
32. Rasko DA & Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9: 117-128.
33. Rasko DA, Moreira CG, Li de R, Reading NC, Ritchie JM, Waldor MK et al. (2008) Targeting QseC signaling and virulence for antibiotic development. Science 321: 1078-1080.
34. Sambanthamoorthy K, Smeltzer MS & Elasri MO (2006) Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus. Microbiology 152: 2559-2572.
35. Shah S, Stapleton PD & Taylor PW (2008) The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus. Lett Appl Microbiol 46: 181-185.
36. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H & Gouaux JE (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274: 1859-1866.
37. Worlitzsch D, Kaygin H, Steinhuber A, Dalhoff A, Botzenhart K & Döring G (2001) Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother 45: 196-202.
38. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV & Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124: 1789-1797.